tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

SRPT Stock Latest News

Sarepta assumed with an Equal Weight at Barclays
The FlySarepta assumed with an Equal Weight at Barclays
3d ago
SRPT
Sarepta price target raised to $22 from $15 at Baird
PremiumThe Fly
Sarepta price target raised to $22 from $15 at Baird
3d ago
SRPT
Sarepta Therapeutics: Safety Uncertainty and Label Risk Overshadow Elevidys Data, Supporting Sell/High Risk Rating
PremiumRatings
Sarepta Therapeutics: Safety Uncertainty and Label Risk Overshadow Elevidys Data, Supporting Sell/High Risk Rating
3d ago
SRPT
H.C. Wainwright reiterates Sell on Sarepta after 3-year data
PremiumThe Fly
H.C. Wainwright reiterates Sell on Sarepta after 3-year data
3d ago
SRPT
Midday Fly By: Minnesota CEOs call for deescalation, Nvidia invests in CoreWeave
PremiumThe Fly
Midday Fly By: Minnesota CEOs call for deescalation, Nvidia invests in CoreWeave
4d ago
LE
AMP
Sarepta rises 14.1%
PremiumThe FlySarepta rises 14.1%
4d ago
SRPT
Morning Movers: USA Rare Earth surges after government funding pact
Premium
The Fly
Morning Movers: USA Rare Earth surges after government funding pact
4d ago
AAUC
CRWV
Sarepta reports ‘positive’ topline three-year EMBARK results for Elevidys
Premium
The Fly
Sarepta reports ‘positive’ topline three-year EMBARK results for Elevidys
4d ago
SRPT
Sarepta to report 3-year topline data from Embark Part 1 study
PremiumThe Fly
Sarepta to report 3-year topline data from Embark Part 1 study
4d ago
SRPT
Sarepta sales of Elevidys ‘cratering fast,’ says H.C. Wainwright
PremiumThe Fly
Sarepta sales of Elevidys ‘cratering fast,’ says H.C. Wainwright
16d ago
SRPT
Tempered Growth Outlook and Heightened Regulatory Risk Drive Sell Rating on Sarepta Therapeutics
PremiumRatings
Tempered Growth Outlook and Heightened Regulatory Risk Drive Sell Rating on Sarepta Therapeutics
17d ago
SRPT
Sarepta price target raised to $19 from $18 at BofA
PremiumThe Fly
Sarepta price target raised to $19 from $18 at BofA
17d ago
SRPT
Balanced Risk Profile Amid Elevidys Uncertainty and PMO Regulatory Headwinds Supports Hold on Sarepta
PremiumRatingsBalanced Risk Profile Amid Elevidys Uncertainty and PMO Regulatory Headwinds Supports Hold on Sarepta
17d ago
SRPT
Sarepta Therapeutics: Resilient Fundamentals, Elevidys Recovery, and Pipeline Catalysts Underscore Attractive Buy‑Rated Upside
Premium
Ratings
Sarepta Therapeutics: Resilient Fundamentals, Elevidys Recovery, and Pipeline Catalysts Underscore Attractive Buy‑Rated Upside
18d ago
SRPT
Sarepta price action likely driven by softer Elevidys Q4 sales, says Jefferies
Premium
The Fly
Sarepta price action likely driven by softer Elevidys Q4 sales, says Jefferies
18d ago
SRPT
Sarepta falls 10% to $21.37 after reporting preliminary Q4 revenue
PremiumThe Fly
Sarepta falls 10% to $21.37 after reporting preliminary Q4 revenue
18d ago
SRPT
Sarepta reports preliminary Q4 net product revenue $369.9M
PremiumThe Fly
Sarepta reports preliminary Q4 net product revenue $369.9M
18d ago
SRPT
Sarepta submits clinical trial application for study SRP-1005-101 to Medsafe
PremiumThe Fly
Sarepta submits clinical trial application for study SRP-1005-101 to Medsafe
23d ago
SRPT
Sarepta Therapeutics Extends Debt Maturities with New Notes
PremiumCompany Announcements
Sarepta Therapeutics Extends Debt Maturities with New Notes
1M ago
8K
SRPT
HHS adds Duchenne muscular dystrophy to recommended screening panel
PremiumThe FlyHHS adds Duchenne muscular dystrophy to recommended screening panel
2M ago
SLDB
SRPT
Vertiv, Affirm, Sarepta, Micron, PepsiCo: Trending by Analysts
Premium
Weekend Updates
Vertiv, Affirm, Sarepta, Micron, PepsiCo: Trending by Analysts
2M ago
MU
PEP
Sarepta put volume heavy and directionally bearish
Premium
The Fly
Sarepta put volume heavy and directionally bearish
2M ago
SRPT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >